Anticoagulant therapy for deep vein thrombosis (DVT) in pregnancy (Q24234729)

Europe PubMed Central

title

Anticoagulant therapy for deep vein thrombosis (DVT) in pregnancy (English)

0 references

0 references

1 reference

1 reference

1 reference

Che Anuar Che Yaakob

1

0 references

Abdulla Abu Dzarr

2

0 references

Ahmad Amir Ismail

3

0 references

Nik Ahmad Zuky Nik Lah

4

0 references

Jacqueline J Ho

Cochrane Database of Systematic Reviews

5

0 references

language of work or name

English

0 references

publication date

2010

0 references

published in

0 references

issue

6

0 references

page(s)

CD007801

0 references

cites work

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238056

Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238056

Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238056

Haemostasis in normal pregnancy: a balancing act?

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238056

Safety profile of different low-molecular weight heparins used at therapeutic dose

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238056

Pharmacotherapy of heparin- induced thrombocytopenia

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238056

Low molecular weight heparin for the treatment of venous thromboembolism in pregnancy: a case series

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238056

Exploring the role of low-molecular-weight heparins in pregnancy

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238056

Review of enoxaparin and its clinical applications in venous and arterial thromboembolism

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238056

Thromboprophylaxis with low molecular weight heparin (dalteparin) in pregnancy

27 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1002/14651858.CD007801.PUB2

Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238056

A randomised double-blind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238056

Absence of transplacental passage of the low molecular weight heparin enoxaparin

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4238056

A randomised double-blind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study

29 November 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002/14651858.CD007801.PUB2